Muthavarapu, Neha

The measurement of physiologic pressure helps diagnose and prevent associated health complications. From typical conventional methods to more complicated modalities, such as the estimation of intracranial pressures, numerous invasive and noninvasive tools that provide us with insight into daily physiology and aid in understanding pathology are within our grasp. Currently, our standards for estimating vital pressures, including continuous BP measurements, pulmonary capillary wedge pressures, and hepatic portal gradients, involve the use of invasive modalities. As an emerging field in medical technology, artificial intelligence (AI) has been incorporated into analyzing and predicting patterns of physiologic pressures. AI has been used to construct models that have clinical applicability both in hospital settings and at-home settings for ease of use for patients. Studies applying AI to each of these compartmental pressures were searched and shortlisted for thorough assessment and review. There are several AI-based innovations in noninvasive blood pressure estimation based on imaging, auscultation, oscillometry and wearable technology employing biosignals. The purpose of this review is to provide an in-depth assessment of the involved physiologies, prevailing methodologies and emerging technologies incorporating AI in clinical practice for each type of compartmental pressure measurement. We also bring to the forefront AI-based noninvasive estimation techniques for physiologic pressure based on microwave systems that have promising potential for clinical practice.

Abstract Blood pressure measurement in current medical practice relies on manual methods with the most widely used modality being sphygmomanometers. Utilizing the principle of Photoplethysmography, it is possible to provide an accurate reading of one’s blood pressure through light signals and photodetector devices. This research paper introduces a new Artificial Intelligence driven approach to predict Blood pressure levels and classify them according to the updated ACC (American College of Cardiology) criteria as Normal, Elevated, Stage I, and II Hypertension from the given PPG signal values using Machine Learning Models. This research paper aims to accurately read the Systolic and Diastolic Blood Pressure using Artificial Intelligence, place them into the correct value bins and further prove that the blood pressure values differ based on different skin tones in different light wavelengths such as red, infrared, and green. Machine Learning models such as the Support Vector Machine have shown an accuracy of 70.58% for Systolic Blood Pressure and Decision Tree with an accuracy of 74.4% for Diastolic Blood Pressure classification. The models used in this research are Support Vector Machine, Decision Tree and K-Nearest Neighbor. This research study has future applications and extensions to predict blood pressure levels for patients with different skin tones under different light radiations and PPG signal readings. Neural Network models will be developed to compare the blood predictions from this work.

Atrial fibrillation (AF) is the most persistent arrhythmia today, with its prevalence increasing exponentially with the rising age of the population. Particularly at elevated heart rates, a functional abnormality known as cardiac alternans can occur prior to the onset of lethal arrhythmias. Cardiac alternans are a beat-to-beat oscillation of electrical activity and the force of cardiac muscle contraction. Extensive evidence has demonstrated that microvolt T-wave alternans can predict ventricular fibrillation vulnerability and the risk of sudden cardiac death. The majority of our knowledge of the mechanisms of alternans stems from studies of ventricular electrophysiology, although recent studies offer promising evidence of the potential of atrial alternans in predicting the risk of AF. Exciting preclinical and clinical studies have demonstrated a link between atrial alternans and the onset of atrial tachyarrhythmias. Here, we provide a comprehensive review of the clinical utility of atrial alternans in identifying the risk and guiding treatment of AF.